We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
Cap. Flow
+$4.07B
Cap. Flow %
3.67%
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548

Sector Composition

Rank Sector Weight
1 Financials 11.15%
2 Technology 9.78%
3 Healthcare 9.21%
4 Consumer Discretionary 6.76%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADEA icon
2176
Adeia
ADEA
$2.94B
$2.2M ﹤0.01%
244,570
-3,625
-1% -$39K
SLGN icon
2177
Silgan Holdings
SLGN
$4.23B
$2.19M ﹤0.01%
73,966
+6,874
+10% +$201K
TG icon
2178
Tredegar Corp
TG
$265M
$2.19M ﹤0.01%
124,975
-5,884
-4% -$123K
POWI icon
2179
Power Integrations
POWI
$3.38B
$2.19M ﹤0.01%
66,562
+2,284
+4% +$75.9K
OA
2180
DELISTED
Orbital ATK, Inc.
OA
$2.19M ﹤0.01%
22,314
-22,799
-51% -$2.11M
PSMT icon
2181
Pricesmart
PSMT
$5.98B
$2.18M ﹤0.01%
23,652
-4,666
-16% -$409K
ABM icon
2182
ABM Industries
ABM
$2.81B
$2.18M ﹤0.01%
49,941
-49,854
-50% -$2.06M
BBT
2183
Beacon Financial Corp
BBT
$2.66B
$2.17M ﹤0.01%
60,319
-7,613
-11% -$269K
CVBF icon
2184
CVB Financial
CVBF
$3.94B
$2.17M ﹤0.01%
98,481
-24,687
-20% -$564K
SRCI
2185
DELISTED
SRC Energy Inc
SRCI
$2.17M ﹤0.01%
256,567
-23,687
-8% -$199K
RYAM.PRA
2186
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
$2.16M ﹤0.01%
21,163
-46,212
-69% -$4.94M
TARO
2187
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.16M ﹤0.01%
18,542
+410
+2% +$45.4K
HRTX icon
2188
Heron Therapeutics
HRTX
$93.9M
$2.16M ﹤0.01%
144,061
+110,539
+330% +$1.53M
CG icon
2189
Carlyle Group
CG
$16.6B
$2.15M ﹤0.01%
135,120
+32,518
+32% +$533K
BANR icon
2190
Banner Corp
BANR
$2.39B
$2.15M ﹤0.01%
38,725
-12,464
-24% -$712K
MDLZ icon
2191
CALL
Mondelez International
MDLZ
$79.5B
$2.15M ﹤0.01%
50,000
-102,600
-67% -$4.55M
OLLI icon
2192
Ollie's Bargain Outlet
OLLI
$4.44B
$2.15M ﹤0.01%
64,221
-3,571
-5% -$112K
FTC icon
2193
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.3B
$2.15M ﹤0.01%
40,855
+35,218
+625% +$1.82M
MYE icon
2194
Myers Industries
MYE
$1.29B
$2.15M ﹤0.01%
135,693
-13,527
-9% -$192K
CLS icon
2195
Celestica
CLS
$38.1B
$2.15M ﹤0.01%
147,943
-50,550
-25% -$675K
SID icon
2196
Companhia Siderúrgica Nacional
SID
$1.31B
$2.15M ﹤0.01%
735,909
+74,312
+11% +$270K
MNRO icon
2197
Monro
MNRO
$383M
$2.15M ﹤0.01%
41,206
-19,590
-32% -$1.11M
MZTI
2198
The Marzetti Company
MZTI
$2.93B
$2.15M ﹤0.01%
16,654
-6,730
-29% -$903K
NWN icon
2199
Northwest Natural Holdings
NWN
$2.06B
$2.14M ﹤0.01%
36,277
-5,573
-13% -$329K
IYK icon
2200
iShares US Consumer Staples ETF
IYK
$1.4B
$2.14M ﹤0.01%
54,000
-35,391
-40% -$1.37M

Similar funds

Credit Suisse's Q1 2017 Portfolio in Review

As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.

  • Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
  • Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
  • Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
  • Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
  • Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
  • Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
  • Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.